Literature DB >> 20566748

Abnormalities in mitochondrial structure in cells from patients with bipolar disorder.

Anne M Cataldo1, Donna L McPhie, Nicholas T Lange, Steven Punzell, Sarah Elmiligy, Nancy Z Ye, Michael P Froimowitz, Linda C Hassinger, Emily B Menesale, Laura W Sargent, David J Logan, Anne E Carpenter, Bruce M Cohen.   

Abstract

Postmortem, genetic, brain imaging, and peripheral cell studies all support decreased mitochondrial activity as a factor in the manifestation of Bipolar Disorder (BD). Because abnormal mitochondrial morphology is often linked to altered energy metabolism, we investigated whether changes in mitochondrial structure were present in brain and peripheral cells of patients with BD. Mitochondria from patients with BD exhibited size and distributional abnormalities compared with psychiatrically-healthy age-matched controls. Specifically, in brain, individual mitochondria profiles had significantly smaller areas, on average, in BD samples (P = 0.03). In peripheral cells, mitochondria in BD samples were concentrated proportionately more within the perinuclear region than in distal processes (P = 0.0008). These mitochondrial changes did not appear to be correlated with exposure to lithium. Also, these abnormalities in brain and peripheral cells were independent of substantial changes in the actin or tubulin cytoskeleton with which mitochondria interact. The observed changes in mitochondrial size and distribution may be linked to energy deficits and, therefore, may have consequences for cell plasticity, resilience, and survival in patients with BD, especially in brain, which has a high-energy requirement. The findings may have implications for diagnosis, if they are specific to BD, and for treatment, if they provide clues as to the underlying pathophysiology of BD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20566748      PMCID: PMC2913344          DOI: 10.2353/ajpath.2010.081068

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

1.  The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia.

Authors:  F M Benes; D Matzilevich; R E Burke; J Walsh
Journal:  Mol Psychiatry       Date:  2006-03       Impact factor: 15.992

Review 2.  Get the balance right: mitofusins roles in health and disease.

Authors:  Ansgar Santel
Journal:  Biochim Biophys Acta       Date:  2006-03-09

3.  Suicide risk in bipolar disorder during treatment with lithium and divalproex.

Authors:  Frederick K Goodwin; Bruce Fireman; Gregory E Simon; Enid M Hunkeler; Janelle Lee; Dennis Revicki
Journal:  JAMA       Date:  2003-09-17       Impact factor: 56.272

Review 4.  Regulation of mitochondrial fusion and division.

Authors:  Kara L Cerveny; Yasushi Tamura; Zhongyan Zhang; Robert E Jensen; Hiromi Sesaki
Journal:  Trends Cell Biol       Date:  2007-10-23       Impact factor: 20.808

5.  Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress.

Authors:  Alipi V Naydenov; Matthew L MacDonald; Dost Ongur; Christine Konradi
Journal:  Arch Gen Psychiatry       Date:  2007-05

6.  DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3.

Authors:  Donna L McPhie; Robert Coopersmith; Andrew Hines-Peralta; Yuzhi Chen; Kathryn J Ivins; Susan P Manly; Michael R Kozlowski; Kim A Neve; Rachael L Neve
Journal:  J Neurosci       Date:  2003-07-30       Impact factor: 6.167

7.  Levels of human Fis1 at the mitochondrial outer membrane regulate mitochondrial morphology.

Authors:  Diana Stojanovski; Olga S Koutsopoulos; Koji Okamoto; Michael T Ryan
Journal:  J Cell Sci       Date:  2004-03-01       Impact factor: 5.285

8.  Molecular evidence for mitochondrial dysfunction in bipolar disorder.

Authors:  Christine Konradi; Molly Eaton; Matthew L MacDonald; John Walsh; Francine M Benes; Stephan Heckers
Journal:  Arch Gen Psychiatry       Date:  2004-03

9.  Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function.

Authors:  M Kvajo; A Dhilla; D E Swor; M Karayiorgou; J A Gogos
Journal:  Mol Psychiatry       Date:  2007-08-07       Impact factor: 15.992

10.  Mitochondrial fission and fusion mediators, hFis1 and OPA1, modulate cellular senescence.

Authors:  Seungmin Lee; Seon-Yong Jeong; Won-Chung Lim; Sujeong Kim; Yong-Yea Park; Xuejun Sun; Richard J Youle; Hyeseong Cho
Journal:  J Biol Chem       Date:  2007-06-01       Impact factor: 5.157

View more
  85 in total

1.  Antidepressant effects of open label treatment with coenzyme Q10 in geriatric bipolar depression.

Authors:  Brent P Forester; David G Harper; Joanna Georgakas; Caitlin Ravichandran; Nethra Madurai; Bruce M Cohen
Journal:  J Clin Psychopharmacol       Date:  2015-06       Impact factor: 3.153

2.  Cocaine use in the past year is associated with altitude of residence.

Authors:  Kristen K Fiedler; Namkug Kim; Douglas G Kondo; Perry F Renshaw
Journal:  J Addict Med       Date:  2012-06       Impact factor: 3.702

3.  Inositol-related gene knockouts mimic lithium's effect on mitochondrial function.

Authors:  Lilach Toker; Yuly Bersudsky; Inbar Plaschkes; Vered Chalifa-Caspi; Gerard T Berry; Roberto Buccafusca; Dieder Moechars; R H Belmaker; Galila Agam
Journal:  Neuropsychopharmacology       Date:  2013-08-08       Impact factor: 7.853

4.  TSPO upregulation in bipolar disorder and concomitant downregulation of mitophagic proteins and NLRP3 inflammasome activation.

Authors:  Giselli Scaini; Tatiana Barichello; Gabriel R Fries; Elizabeth A Kennon; Taylor Andrews; Bobby R Nix; Giovana Zunta-Soares; Samira S Valvassori; Jair C Soares; João Quevedo
Journal:  Neuropsychopharmacology       Date:  2018-12-11       Impact factor: 7.853

5.  Physical Exercise for Treatment of Mood Disorders: A Critical Review.

Authors:  C M Hearing; W C Chang; K L Szuhany; T Deckersbach; A A Nierenberg; L G Sylvia
Journal:  Curr Behav Neurosci Rep       Date:  2016-10-14

6.  In vitro effects of antidepressants and mood-stabilizing drugs on cell energy metabolism.

Authors:  Tereza Cikánková; Zdeněk Fišar; Jana Hroudová
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-19       Impact factor: 3.000

Review 7.  Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia: Possible Interactions with Cellular Processes.

Authors:  Oded Bergman; Dorit Ben-Shachar
Journal:  Can J Psychiatry       Date:  2016-08       Impact factor: 4.356

8.  Abnormal high-energy phosphate molecule metabolism during regional brain activation in patients with bipolar disorder.

Authors:  C Yuksel; F Du; C Ravichandran; J R Goldbach; T Thida; P Lin; B Dora; J Gelda; L O'Connor; S Sehovic; S Gruber; D Ongur; B M Cohen
Journal:  Mol Psychiatry       Date:  2015-03-10       Impact factor: 15.992

Review 9.  Intracellular Signaling Cascades in Bipolar Disorder.

Authors:  Gregory H Jones; Carola Rong; Aisha S Shariq; Abhinav Mishra; Rodrigo Machado-Vieira
Journal:  Curr Top Behav Neurosci       Date:  2021

10.  Perturbational Profiling of Metabolites in Patient Fibroblasts Implicates α-Aminoadipate as a Potential Biomarker for Bipolar Disorder.

Authors:  Joanne H Huang; Shaunna S Berkovitch; Jonathan Iaconelli; Bradley Watmuff; Hyoungjun Park; Shrikanta Chattopadhyay; Donna McPhie; Dost Öngür; Bruce M Cohen; Clary B Clish; Rakesh Karmacharya
Journal:  Mol Neuropsychiatry       Date:  2016-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.